HUE028293T2 - Honey Composition with L-Alanyl-L-Glutamine - Google Patents
Honey Composition with L-Alanyl-L-Glutamine Download PDFInfo
- Publication number
- HUE028293T2 HUE028293T2 HUE12723520A HUE12723520A HUE028293T2 HU E028293 T2 HUE028293 T2 HU E028293T2 HU E12723520 A HUE12723520 A HU E12723520A HU E12723520 A HUE12723520 A HU E12723520A HU E028293 T2 HUE028293 T2 HU E028293T2
- Authority
- HU
- Hungary
- Prior art keywords
- composition
- honey
- sleep
- alanyl
- glutamine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 86
- 235000012907 honey Nutrition 0.000 title claims description 56
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 title description 52
- 229960002648 alanylglutamine Drugs 0.000 title description 41
- 230000007958 sleep Effects 0.000 claims description 43
- 239000000047 product Substances 0.000 claims description 33
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 210000004556 brain Anatomy 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000003085 diluting agent Substances 0.000 claims description 6
- 206010022437 insomnia Diseases 0.000 claims description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 201000002859 sleep apnea Diseases 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 239000002002 slurry Substances 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 239000013066 combination product Substances 0.000 claims 1
- 229940127555 combination product Drugs 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 238000011450 sequencing therapy Methods 0.000 claims 1
- 241001080024 Telles Species 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 230000003860 sleep quality Effects 0.000 description 8
- 229920002527 Glycogen Polymers 0.000 description 7
- 229940096919 glycogen Drugs 0.000 description 7
- 230000004617 sleep duration Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000002490 cerebral effect Effects 0.000 description 5
- 230000006266 hibernation Effects 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 241000257303 Hymenoptera Species 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000000422 nocturnal effect Effects 0.000 description 4
- 208000019116 sleep disease Diseases 0.000 description 4
- 230000002618 waking effect Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 description 3
- 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 description 3
- 208000009233 Morning Sickness Diseases 0.000 description 3
- 208000034850 Vomiting in pregnancy Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000478 neocortex Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 230000009889 stress physiology Effects 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
- Seasonings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1108343.3A GB201108343D0 (en) | 2011-05-18 | 2011-05-18 | Honey composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE028293T2 true HUE028293T2 (en) | 2016-12-28 |
Family
ID=44260736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12723520A HUE028293T2 (en) | 2011-05-18 | 2012-05-16 | Honey Composition with L-Alanyl-L-Glutamine |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10314879B2 (https=) |
| EP (1) | EP2709638B1 (https=) |
| JP (2) | JP6328552B2 (https=) |
| KR (1) | KR101900904B1 (https=) |
| CN (2) | CN103747791B (https=) |
| AU (1) | AU2012257566B2 (https=) |
| CA (1) | CA2834182C (https=) |
| CY (1) | CY1117053T1 (https=) |
| DK (1) | DK2709638T3 (https=) |
| ES (1) | ES2553655T3 (https=) |
| GB (1) | GB201108343D0 (https=) |
| HR (1) | HRP20151320T1 (https=) |
| HU (1) | HUE028293T2 (https=) |
| MX (1) | MX337139B (https=) |
| PL (1) | PL2709638T3 (https=) |
| PT (1) | PT2709638E (https=) |
| RS (1) | RS54412B1 (https=) |
| SI (1) | SI2709638T1 (https=) |
| SM (1) | SMT201600056B (https=) |
| WO (1) | WO2012156731A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
| EP3490971A4 (en) * | 2016-08-01 | 2020-02-26 | Filament Biosolutions Inc. | METHODS OF TREATING AND PREVENTING SIDE EFFECTS OF CANCER TREATMENT |
| AU2017385151B2 (en) * | 2016-12-30 | 2021-03-25 | Innobio Corporation Limited | Gene which encodes alanyl-glutamine dipeptide biosynthetic enzyme and application thereof |
| CN113040393A (zh) * | 2021-03-31 | 2021-06-29 | 杨继辉 | 一种干预焦虑睡眠障碍的营养配方 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2919059A1 (de) | 1979-05-10 | 1980-11-20 | Josef Dipl Chem Dr Rer N Klosa | Diaetetisches mittel und verfahren zu seiner herstellung |
| US4532143A (en) * | 1984-06-15 | 1985-07-30 | The J. M. Smucker Company | Spreadable honey |
| US4973491A (en) * | 1989-06-06 | 1990-11-27 | Ontario Ministry Of Agriculture And Food | Honey product |
| JP2829793B2 (ja) | 1991-01-10 | 1998-12-02 | 長谷川香料株式会社 | 飲食品の蜂蜜様風味改善方法 |
| GB9121467D0 (en) | 1991-10-10 | 1991-11-27 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| JP3473976B2 (ja) * | 1992-10-29 | 2003-12-08 | 協和醗酵工業株式会社 | アラニルグルタミンの製造法 |
| NZ538405A (en) | 2002-08-01 | 2007-12-21 | Aesgen Inc | Improved treatment of cancer with glutamine and carbohydrate |
| JP4595651B2 (ja) * | 2005-04-25 | 2010-12-08 | 株式会社デンソー | 生体センサ、睡眠情報処理方法、及び睡眠情報処理装置 |
| CN101287458A (zh) * | 2005-10-12 | 2008-10-15 | 株式会社大塚制药工场 | 低血糖症状抑制用组合物 |
| CN101312660B (zh) * | 2005-11-23 | 2013-07-17 | 可口可乐公司 | 供体重管理之高效甜味剂以及经彼甜化的组成物 |
| JPWO2007119503A1 (ja) | 2006-03-23 | 2009-08-27 | 協和発酵バイオ株式会社 | 寝起き改善剤 |
| JP5138581B2 (ja) * | 2006-03-23 | 2013-02-06 | 協和発酵バイオ株式会社 | 筋肉疲労改善剤 |
| JP5046364B2 (ja) * | 2006-09-15 | 2012-10-10 | パナソニック株式会社 | 睡眠状況評価システム及びそのプログラム |
| CN101041008A (zh) | 2007-04-28 | 2007-09-26 | 王军 | 三冬丹 |
| EP2177113A1 (en) | 2008-10-15 | 2010-04-21 | Nestec S.A. | Improved liver glycocen synthesis |
| JP2010260853A (ja) * | 2009-04-08 | 2010-11-18 | Kyowa Hakko Bio Co Ltd | アラニルグルタミンを含有する造粒粉末、顆粒または錠剤 |
| CN101999572A (zh) | 2010-11-08 | 2011-04-06 | 王福起 | 助眠蜜及制备方法 |
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
-
2011
- 2011-05-18 GB GBGB1108343.3A patent/GB201108343D0/en not_active Ceased
-
2012
- 2012-05-16 PL PL12723520T patent/PL2709638T3/pl unknown
- 2012-05-16 PT PT127235208T patent/PT2709638E/pt unknown
- 2012-05-16 ES ES12723520.8T patent/ES2553655T3/es active Active
- 2012-05-16 RS RS20150811A patent/RS54412B1/sr unknown
- 2012-05-16 DK DK12723520.8T patent/DK2709638T3/da active
- 2012-05-16 SI SI201230398T patent/SI2709638T1/sl unknown
- 2012-05-16 CN CN201280023801.9A patent/CN103747791B/zh not_active Expired - Fee Related
- 2012-05-16 EP EP12723520.8A patent/EP2709638B1/en active Active
- 2012-05-16 KR KR1020137032788A patent/KR101900904B1/ko not_active Expired - Fee Related
- 2012-05-16 CN CN201810011129.0A patent/CN108159391A/zh active Pending
- 2012-05-16 HU HUE12723520A patent/HUE028293T2/en unknown
- 2012-05-16 MX MX2013012967A patent/MX337139B/es active IP Right Grant
- 2012-05-16 JP JP2014510877A patent/JP6328552B2/ja not_active Expired - Fee Related
- 2012-05-16 WO PCT/GB2012/051090 patent/WO2012156731A1/en not_active Ceased
- 2012-05-16 AU AU2012257566A patent/AU2012257566B2/en not_active Ceased
- 2012-05-16 HR HRP20151320TT patent/HRP20151320T1/hr unknown
- 2012-05-16 CA CA2834182A patent/CA2834182C/en active Active
- 2012-05-16 US US14/114,649 patent/US10314879B2/en active Active
-
2015
- 2015-12-17 CY CY20151101156T patent/CY1117053T1/el unknown
-
2016
- 2016-02-24 SM SM201600056T patent/SMT201600056B/xx unknown
- 2016-10-27 JP JP2016210960A patent/JP6336003B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-25 US US16/283,918 patent/US20190192612A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1196097A1 (en) | 2014-12-05 |
| SI2709638T1 (sl) | 2016-01-29 |
| US20140186457A1 (en) | 2014-07-03 |
| MX2013012967A (es) | 2014-05-13 |
| JP6336003B2 (ja) | 2018-06-06 |
| JP6328552B2 (ja) | 2018-05-23 |
| JP2017061488A (ja) | 2017-03-30 |
| CA2834182A1 (en) | 2012-11-22 |
| CA2834182C (en) | 2021-05-18 |
| PL2709638T3 (pl) | 2016-03-31 |
| EP2709638A1 (en) | 2014-03-26 |
| AU2012257566A1 (en) | 2013-11-14 |
| CN103747791A (zh) | 2014-04-23 |
| KR20140058435A (ko) | 2014-05-14 |
| CN108159391A (zh) | 2018-06-15 |
| JP2014513713A (ja) | 2014-06-05 |
| AU2012257566B2 (en) | 2017-03-02 |
| SMT201600056B (it) | 2016-04-29 |
| WO2012156731A1 (en) | 2012-11-22 |
| US10314879B2 (en) | 2019-06-11 |
| CN103747791B (zh) | 2018-01-30 |
| CY1117053T1 (el) | 2017-04-05 |
| RS54412B1 (sr) | 2016-04-28 |
| US20190192612A1 (en) | 2019-06-27 |
| PT2709638E (pt) | 2016-01-07 |
| KR101900904B1 (ko) | 2018-09-21 |
| GB201108343D0 (en) | 2011-06-29 |
| ES2553655T3 (es) | 2015-12-10 |
| HRP20151320T1 (hr) | 2016-01-15 |
| DK2709638T3 (da) | 2015-12-21 |
| EP2709638B1 (en) | 2015-09-30 |
| MX337139B (es) | 2016-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6092836B2 (ja) | ヒドロキシ酪酸エステル及びその医学的使用 | |
| AU1499901A (en) | Natural composition and method for the treatment of sexual dysfunction | |
| CN102438642A (zh) | 包含绿茶提取物的组合物 | |
| US20190192612A1 (en) | Honey composition with l-alanyl-l-glutamine | |
| JP6166786B2 (ja) | 脳機能低下の予防または改善剤 | |
| JPH0952828A (ja) | アミノ酸組成剤およびその使用方法 | |
| De Vries et al. | Studies on amino acid metabolism. II. Blood glycine and total amino acids in various pathological conditions, with observations on the effects of intravenously administered glycine | |
| CN101618044B (zh) | 含有人参皂苷、三七皂苷和氨基酸的胶囊及其制备方法 | |
| CN109260205B (zh) | 一种汉防己甲素在制备抗糖尿病合并高血压药物中的应用 | |
| CN103479743B (zh) | 治疗老年痴呆的药物组合物及其制备方法 | |
| CN106214631A (zh) | 一种治疗偏头痛的口服糖浆及其制备方法 | |
| JP2012126716A (ja) | 認知症の予防・治療に有効な組成物及びそれを含有する漢方・生薬製剤 | |
| CN101623432A (zh) | 加减玉女煎在制备治疗甲状腺功能亢进症的药物中的应用 | |
| HK1196097B (en) | Honey composition with l-alanyl- l- glutamine | |
| CN1061256C (zh) | 外涂降压膏 | |
| EP4563012A1 (en) | Use of bovine spleen peptide powder in improving sleep, preventing or treating depression, or improving intestinal function | |
| CN104606203B (zh) | 一种用于治疗斑秃的外用搽剂及其制备方法 | |
| CN101939013B (zh) | 组合物用于制备纤维肌痛综合症以及血管平滑肌痉挛引起的疼痛的药物的用途 | |
| JPH0826987A (ja) | アシルカルニチン含有製剤 | |
| CN120345711A (zh) | 一种降尿酸和缓解痛风性关节炎的蛹虫草低聚肽组合物、制备方法及应用 | |
| US20250090615A1 (en) | Multivitamin for auxiliary regulation of blood pressure and preparation method and application thereof | |
| CN102579572A (zh) | 救心滴丸生产工艺 | |
| Dharmananda | Rare reactions to a safe herb | |
| SUMITOMO et al. | Cardiopulmonary Arrest After Severe Anaphylactic Reaction to Second | |
| Street | THE GLYCEROPHOSPHATES |